NASDAQ: FEMY - Femasys Inc.

Rentabilidad a seis meses: +1.8%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Calendario de promoción Femasys Inc.

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa Femasys Inc.

Femasys Inc., a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally.

más detalles
The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. In addition, the company provides non-surgical product technologies. It offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

IPO date 2021-06-18
ISIN US31447E1055
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.femasys.com
Цена ао 1.5
Cambio de precio por día: -1.74% (1.15)
Cambio de precio por semana.: +3.67% (1.09)
Cambio de precio por mes: +8.65% (1.04)
Cambio de precio en 3 meses.: +0.8929% (1.12)
Cambio de precio en seis meses: +1.8% (1.11)
Cambio de precio por año: +15.9% (0.975)
Cambio de precio en 3 años.: -72.57% (4.12)
Cambio de precio en 5 años.: 0% (1.13)
Cambio de precio en 10 años.: 0% (1.13)
Cambio de precio desde principios de año.: -15.04% (1.33)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 13.28 1
P/BV 0.7754 9
P/E 0 0
EV/EBITDA 0.0577 10
Total: 5

Eficiencia

Nombre Significado Calificación
ROA, % -51.33 0
ROE, % -77.63 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -0.343 10
Total: 9.6

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 15.39 3
Rentabilidad Ebitda, % 29.11 4
Rentabilidad EPS, % -25.6 0
Total: 2.2
Más detalles

Instituciones Volumen Compartir, %
Clear Street LLC 249900 1.15
Clear Creek Financial Management, LLC 236769 1.09
Bank of America Corporation 165043 0.76
CM Management, LLC 125000 0.58
Barclays PLC 99003 0.46
Vanguard Group Inc 87623 0.4
Tri Locum Partners, LP 76605 0.35
Geode Capital Management, LLC 75902 0.35
Sassicaia Capital Advisers, LLC 71931 0.33
Renaissance Technologies, LLC 69126 0.32



Supervisor Título profesional Pago año de nacimiento
Mr. Dov Elefant Chief Financial Officer 595.14k 1967 (58 años)
Mr. Daniel Scott Currie COO, Senior VP & Secretary 548.15k 1964 (61 año)
Ms. Mary An Merchant J.D., Ph.D. Vice President of Counsel & Intellectual Property N/A
Dr. Jeffrey Marcus M.D., M.S. Chief Medical Advisor N/A
Ms. Christine Thomas Senior VP of Regulatory & Clinical Affairs N/A 1973 (52 año)
Dr. James H. Liu M.D. Chief Medical Officer N/A
Mr. Richard Spector Chief Commercial Officer N/A 1971 (54 año)
Ms. Kathy Lee-Sepsick M.B.A. Founder, President, CEO & Director 804.67k 1968 (57 años)
Ms. Sue Owens Vice President of Sales
Ms. Naomi Phaneuf Vice President of Marketing

DIRECCIÓN: United States, Suwanee. GA, 3950 Johns Creek Court - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.femasys.com